Durvalumab vs Rivaroxaban

## Durvalumab vs Rivaroxaban: Overview

This comparison examines the pharmacological differences between **Durvalumab** and **Rivaroxaban**.

## Mechanism of Action

**Durvalumab**: Human IgG1 kappa anti-PD-L1 monoclonal antibody blocking PD-L1 binding to PD-1 and CD80.

**Rivaroxaban**: Direct Factor Xa inhibitor.

## Pharmacokinetics

**Half-life**: Durvalumab — 17 days; Rivaroxaban — 5-9 hours.

## Chemical Properties

**Molecular Formula**: Durvalumab — N/A; Rivaroxaban — C19H18ClN3O5S.

**Molecular Weight**: Durvalumab — N/A; Rivaroxaban — 435.8820 g/mol.

**Type**: Durvalumab — Antibody; Rivaroxaban — Small molecule.